DARWIN Study: A Randomization/Withdrawal Efficacy Study of Dexloxiglumide in Constipation-Predominant Irritable Bowel Syndrome (C-IBS)

Clinical trial NCT00220090 · COMPLETED

Trial details

NCT number: NCT00220090
Sponsor: Rottapharm
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Irritable Bowel Syndrome

Start date: 2003-07-01
Primary completion: 2006-09-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.